Optellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…

Continue ReadingOptellum recognised by the NHS and Health Education England and included as one of two case studies in AI Roadmap report

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

Oxford, UK/Chalfont St Giles 26 November 2021 13:00 GMT - GE Healthcare and Optellum today announced that they have signed a letter of intent to collaborate to advance precision diagnosis…

Continue ReadingPRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

Rapidly growing lung health startup aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software. OXFORD, UK / HOUSTON, USA – August 18, 2021: Optellum,…

Continue ReadingPRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment

AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…

Continue ReadingAI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

European consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung nodule malignancy. As discussed in earlier news stories, there has…

Continue ReadingEuropean consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

PRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology

Oxford-based company Optellum, supported by NHS collaborations and grant funding, launches the world’s first AI decision support for early lung cancer • Ground-breaking machine-learning neural network can recognise the signs…

Continue ReadingPRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology